SECURKLOUD

Healthcare Triangle, Inc. has signed a Letter of Intent to acquire Spain-based Teyame.AI, a move expected to generate approximately $34 million in incremental annual revenue and $4.2 million in additional EBITDA. The acquisition will combine Teyame.AI's advanced AI automation platform-currently serving banking and insurance clients and piloting healthcare applications-with Healthcare Triangle's expertise in clinical systems. This integration aims to create a comprehensive, AI-powered patient engagement platform and expand the company's reach into international markets. The announcement was made by Healthcare Triangle, Inc.

Healthcare Triangle Inc. has signed a non-binding Letter of Intent to acquire the assets of Teyame.AI LLC, a Spain-based company specializing in AI-powered omnichannel customer experience solutions. The proposed acquisition would bring Teyame's advanced AI automation platform under Healthcare Triangle's umbrella, with the aim of creating a next-generation global customer engagement ecosystem for healthcare. Teyame is projected to generate approximately $34 million in revenue and $4.2 million in EBITDA for fiscal year 2025. The integration is expected to enable intelligent automation for treatment plans, chronic care workflows, and patient outreach, while also expanding Healthcare Triangle's reach into international markets and enhancing its innovation team with Teyame's AI and automation experts.

Healthcare Triangle Inc. has announced that it has entered into warrant exercise agreements with certain accredited and institutional investors, resulting in the immediate exercise of outstanding warrants to purchase 812,775 shares of common stock. This transaction will generate approximately $1.63 million in gross proceeds for the company. In connection with the exercise, the company has agreed to reduce the exercise price of the existing warrants from $20.92 to $2.00 per share. Participating investors will also receive new unregistered warrants to purchase up to 812,775 shares of common stock at an exercise price of $3.00 per share, exercisable upon stockholder approval and expiring five years from that date. WallachBeth Capital is acting as the sole placement agent for this warrant inducement transaction.

Healthcare Triangle Inc. (Nasdaq: HCTI) has announced a private placement transaction involving the exercise of outstanding warrants by certain accredited and institutional investors. The company has entered into agreements for the immediate exercise of warrants to purchase a total of 377,702 shares of common stock, generating approximately $755,000 in gross cash proceeds. In return, participating investors will receive new unregistered warrants to purchase up to 377,702 additional shares at an exercise price of $3.00 per share. The new warrants are immediately exercisable and will expire five years from the date of issuance. As part of the transaction, the exercise price of the existing warrants was reduced from $20.92 to $2.00 per share. WallachBeth Capital is serving as financial advisor for the transaction.

Healthcare Triangle Inc. has announced that key resolutions have been approved by its majority shareholder, Suresh Venkatachari, who holds 81.82% of the company's voting power. The actions were taken as of September 19, 2025, with shareholders of record on that date being notified. The full filing can be accessed through the link below.

Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record (EMR) platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.

Healthcare Triangle Inc. has announced that its 2025 Annual Meeting of Stockholders will be held virtually on October 31, 2025. During the meeting, stockholders will be asked to vote on the election of four nominees for director and the ratification of the appointment of the company's independent registered public accounting firm.

Healthcare Triangle, Inc. (Nasdaq: HCTI) announced a 1-for-249 reverse stock split, effective August 1, 2025, as part of its strategy to comply with Nasdaq's $1.00 minimum bid price requirement. The company's common stock will continue trading under the symbol "HCTI," with a new CUSIP number 42227W 306. The reverse split is intended to increase the stock's price per share.

Healthcare Triangle Inc. has announced a regulatory issue concerning its continued listing on the Nasdaq Stock Market. The company received notices from Nasdaq indicating non-compliance with several listing rules. Initially, the company failed to meet the Minimum Bid Price Requirement, with its securities trading below $1 for 30 consecutive days. Further, Nasdaq raised public interest concerns due to substantial shareholder dilution from a private placement. Additionally, the company's securities recorded a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule. Healthcare Triangle Inc. has responded to the Nasdaq Hearings Panel and is exploring alternative actions to regain compliance. However, there is no assurance of meeting the necessary listing requirements.